Know where your UK POM digital estate stands — and what to fix.

We’ve assessed 100 UK Prescription Only Medicine (POM) companies against the same eight-dimension framework. This is your private version of that benchmark — a scored, evidence-based review of your digital product-information estate. Delivered as a ready-to-use report your team can act on.

Sample report pageWhat the review covers:

  • Your maturity score across eight dimensions, benchmarked against your therapy area peers AND the wider 100-company benchmark
  • A traffic light read of every dimension — what’s strong, what’s at risk, and what it means in practice
  • A live check of your digital estate: how your products are findable, how HCP and patient routes work, and how prescribing information and adverse event reporting are handled
  • Prioritised quick wins and strategic opportunities, framed as observations — not a verdict
  • A “what good looks like” reference from the highest-scoring comparable company in the benchmark, used as a direction of travel rather than a deficit

Who it’s for:

Digital, medical affairs, marketing or comms leads who want an objective, external read on how their UK product-information estate compares — and a clear starting point for improving it.

Complete the form and we’ll be in touch to confirm scope and pricing — typically a short email exchange or a brief call, whichever you prefer.

This field is for validation purposes and should be left unchanged.
Name(Required)